Skip to main content

EPIGENETICA DEL PROCESO DE TRANSICION DE EPITELIO A MESENQUIMA Y SU REVERSION

BFU2017-85420-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Obesity-Induced Astrogliosis Is Regulated by the Diabesity Factor HMG20A

  • Mellado-Gil, José Manuel
  • Fuente-Martín, Esther
  • Lorenzo, Petra Isabel
  • Cobo-Vuilleumier, Nadia
  • Guerrero-Martínez, José A.
  • Romero-Zerbo, Silvana Y.
  • Franco, Jaime M.
  • Pérez-Cabello, Jesús Ángel
  • Álvarez-Dolado, Manuel
  • Pozo, David
  • Bermúdez-Silva, Francisco Javier
  • Reyes, José C.
  • Gauthier, Benoit R.
Resumen del trabajo presentado en el American Diabetes Association Meeting (2020), celebrado online del 12 al 16 de junio de 2020, It is well established that systemic glucose homeostasis is imparted by an intricate cross-talk among several organs including the central nervous system (CNS) and pancreatic islets. In analogy to islet beta cells, hypothalamic astrocytes are glucose sensors that facilitate the CNS response to changing metabolic environment. Therefore, astrocytes and beta cells may share a common genetic signature implicated in coupling glucose metabolism to cellular output. We recently demonstrated that the diabesity factor HMG20A is essential for beta-cell functional maturity and adaptation to physiological stress (obesity, type 2 diabetes and pregnancy). As this chromatin remodelling factor also dictates CNS development, we sought to determine whether HMG20A is expressed in astrocytes and whether it potentiates astrocyte function in response to environmental cues. We found that HMG20A is expressed in hypothalamic astrocytes and is upregulated in diet-induced obesity and glucose-intolerant mice, correlating with increased transcript levels of GFAP and IL-1β, indicative of reactive astrocytes (astrogliosis). High glucose, but not lipids, transiently decreased HMG20A expression in isolated mouse primary astrocytes. HMG20A silencing in astrocytes resulted in repression of pro-inflammatory as well as lipid and glucose metabolism genes. These pathways are up-regulated in activated astrocytes (astrogliosis) to resolve stress conditions. As such astrocyte depleted of HMG20A were more susceptible to cell death. Furthermore, motor neuron viability in astrocyte conditioned media was significantly hindered after HMG20A depletion in astrocytes. We posit that HMG20A is involved in the astrocyte polarization state. Under physiological pressure such as obesity, HMG20A expression may be transiently decreased by high glucose but long-term it is increased to induce astrogliosis in an attempt to preserve the neuronal network and glucose homeostasis., ISCIII (PI13/00593 to B.R.G.), (PI13/00309 to F.J.B-S.); Ministerio de Economia y Competidividad/Fondos FEDER (PI10/00871, PI13/00593, BFU2017-83588-P to B.R.G.); BFU2017-85420-R (to J.C.R.); (JCI-2012-12491, IJCI-2015-26238 to E.F-M.); Consejería de Salud Junta de Andalucía (PI-0006-2016 to E.F-M.), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Regulation of enhancers, co-expression domains and splicing efficiency by TGFß

  • Guerrero-Martínez, José A.
  • Sánchez-Escabias, Elena
  • Gómez-Marín, Elena
  • Basurto-Cayuela, Laura
  • Pozuelo-Sánchez, Isabel
  • Ceballos-Chávez, María
  • Reyes, José C.
Resumen del trabajo presentado en la I Reunión de la Red de Excelencia Temática, celebrada en Sevilla (España), los días 12 y 13 de julio de 2021, TGFβ cytokines have crucial roles in development, proliferation, tissue homeostasis, differentiation and immune regulation. Consequently, alterations in TGFβ signaling underlie numerous diseases, including cancer. TGFβ is one of the most potent inductors of epithelial to mesenchymal transition (EMT) in normal and oncogenic epithelial cells from different origins. EMT and its reversion (MET) are common processes during embryonic development and have attracted considerable interest due to the fact that they seem to be related to tumor cells dissemination and migration, generation of tumor circulating cells, cancer stem cells and metastasis formation. TGFβ causes a large reorganization of gene expression patterns and epigenetic information, that we are only starting to understand. In our group we are investigating how TGFβ causes these reorganization of gene expression patterns. We have cartographied the genomic transcriptional enhancers that are regulated by TGFβ in a breast epithelial cell line. In fact, TGFβ triggers a fast and widespread increase in chromatin accessibility in about 80% of enhancers, irrespective of whether they are activated, repressed or not regulated by TGFβ. We have also shown that most TGFβ-regulated genes are located around enhancers regulated in the same way, often creating domains of several co-regulated genes that we term TGFβ regulatory domains (TRD). We are currently investigating how the 3D organization of the genome connect the enhancers with the TRDs. We have also investigated whether regulation co-transcriptional splicing efficiency at the whole gene level is used to regulate gene expression by TGFβ. First we found that the existence of two well-differentiated strategies for co-transcriptional splicing efficiency, at the extremes of a gradient: short genes, that produces high levels of pre-mRNA display a relatively inefficient splicing while long genes with relatively low pre-mRNA levels present efficient splicing. Furthermore, we found that the TGFβ pathway regulates the general co-transcriptional splicing efficiency causing changes in mature mRNA levels. Taken together, our data indicate that co-transcriptional splicing efficiency is a gene-specific characteristic that can be regulated to control gene expression. Finally, other members of the group are looking for chromatin factors that control gene expression changes caused by TGFβ., This work was funded by the Spanish Ministry of Economy and Competitiveness (BFU2014-53543-P and BFU2017-85420-R), by Junta de Andalucía (P18-FR-1962) and by Fundación Vencer el Cáncer (VEC – 001/2014 FVEC-FPS)